{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:05:51Z","timestamp":1777446351242,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/bf03346381","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:44:42Z","timestamp":1396043082000},"page":"389-392","source":"Crossref","is-referenced-by-count":13,"title":["Soluble adhesion molecules levels in patients with Cushing\u2019s syndrome before and after cure"],"prefix":"10.1007","volume":"31","author":[{"given":"F.","family":"Ermetici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Malavazos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Corbetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Eller-Vainicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cannavo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ambrosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"issue":"Suppl1","key":"BF03346381_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2005-861363","volume":"37","author":"MT Schram","year":"2005","unstructured":"Schram MT, Stehouwer CDA. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res 2005, 37(Suppl 1): 49\u201355.","journal-title":"Horm Metab Res"},{"key":"BF03346381_CR2","first-page":"543","volume":"77","author":"JF Leeuwenberg","year":"1992","unstructured":"Leeuwenberg JF, Smeets EF, Neefjes JJ, et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992, 77: 543\u20139.","journal-title":"Immunology"},{"key":"BF03346381_CR3","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI118175","volume":"96","author":"AM Schmidt","year":"1995","unstructured":"Schmidt AM, Hori O, Chen JX, et al. Advanced glycation end-products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995, 96: 1395\u2013403.","journal-title":"J Clin Invest"},{"key":"BF03346381_CR4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","volume":"61","author":"T Mancini","year":"2004","unstructured":"Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G. High cardiovascular risk in patients with Cushing\u2019s syndrome according to 1999 WHO\/ISH guidelines. Clin Endocrinol (Oxf) 2004, 61: 768\u201377.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03346381_CR5","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","volume":"88","author":"A Faggiano","year":"2003","unstructured":"Faggiano A, Pivonello R, Spiezia S, et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003, 88: 2527\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346381_CR6","first-page":"39","volume":"5","author":"DH Jurgilewicz","year":"2002","unstructured":"Jurgilewicz DH, Rogowski F, Lebkowska U, Citko A, Jaroszewicz E, Parfienczyk A. E-selectin, L-selectin, ICAM-1 and IL-6 concentrations changes in the serum of patients with hyperthyroidism in the early period of radioiodine 1\u2013131 therapy. Nucl Med Rev Cent East Eur 2002, 5: 39\u201342.","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"BF03346381_CR7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1196\/annals.1365.015","volume":"1092","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Paterakis T, Kandarakis HA. Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci 2006, 1092: 175\u201386.","journal-title":"Ann N Y Acad Sci"},{"key":"BF03346381_CR8","doi-asserted-by":"crossref","first-page":"H436","DOI":"10.1152\/ajpheart.00587.2004","volume":"288","author":"SC Sch\u00e4fer","year":"2005","unstructured":"Sch\u00e4fer SC, Wallerath T, Closs EI, et al. Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles. Am J Physiol Heart Circ Physiol 2005, 288: H436\u201344.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BF03346381_CR9","doi-asserted-by":"crossref","first-page":"H1922","DOI":"10.1152\/ajpheart.00364.2002","volume":"283","author":"KM Rogers","year":"2002","unstructured":"Rogers KM, Bonar CA, Estrella JL, Yang S. Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am J Physiol Heart Circ Physiol 2002, 283: H1922\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BF03346381_CR10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2265.2007.02774.x","volume":"66","author":"E Setola","year":"2007","unstructured":"Setola E, Losa M, Lanzi R, et al. Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing\u2019s disease from metabolic syndrome. Clin Endocrinol (Oxf) 2007, 66: 586\u201392.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03346381_CR11","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 2003, 88: 5593\u201302.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346381_CR12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1530\/eje.0.1430227","volume":"143","author":"P Colombo","year":"2000","unstructured":"Colombo P, Dall\u2019Asta C, Barbetta L, et al. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing\u2019s disease. Eur J Endocrinol 2000, 143: 227\u201334.","journal-title":"Eur J Endocrinol"},{"key":"BF03346381_CR13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1440-1681.2002.03672.x","volume":"29","author":"H Ito","year":"2002","unstructured":"Ito H, Ohshima A, Inoue M, et al. Weight reduction decreases soluble cellular adhesion molecules in obese women. Clin Exp Pharmacol Physiol 2002, 29: 399\u2013404.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF03346381_CR14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/07435800009048601","volume":"26","author":"T Suzuki","year":"2000","unstructured":"Suzuki T, Shibata H, Ando T, et al. Risk factors associated with persistent postoperative hypertension in Cushing\u2019s syndrome. Endocr Res 2000, 26: 791\u20135.","journal-title":"Endocr Res"},{"key":"BF03346381_CR15","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"Filipsson H, Monson JP, Koltowska-H\u00e4ggstr\u00f6m M, Mattsson A, Johannsson G. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 2006, 91: 3954\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346381_CR16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2265.2003.01894.x","volume":"59","author":"FM Swords","year":"2003","unstructured":"Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF, Monson JP. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement. Clin Endocrinol (Oxf) 2003, 59: 613\u201320.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346381\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T12:56:20Z","timestamp":1716641780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["BF03346381"],"URL":"https:\/\/doi.org\/10.1007\/bf03346381","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}